Biokangtai News and Activities

Biokangtai is one of the...

• CSI 500;
• TOB Iconic 10,000.

Biokangtai is a company listed under the stock ticker 300601 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Biokangtai

• Weimin Du, Chairman of the Board
• Keping Hu, Independent Director
• Jiaoyu Li, Independent Director

Create your alert
to follow the executive moves at Biokangtai.

Biokangtai has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Biokangtai

• BioKangtai signs license agreement with AstraZeneca_Limited by Share Ltd, Shenzhen, Kangtai biologics

Social media about Biokangtai

• Biokangtai on Wikipedia, Google News & Yahoo Finance
• Biokangtai on LinkedIn, X (Twitter) & YouTube